Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 505041, 10 pages
http://dx.doi.org/10.1155/2014/505041
Research Article

Single Amino Acid Arginine Deprivation Triggers Prosurvival Autophagic Response in Ovarian Carcinoma SKOV3

1Institute of Cell Biology, National Academy of Sciences of Ukraine, Drahomanov Street 14/16, Lviv 79005, Ukraine
2Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale, Via P. Solaroli 17, 28100 Novara, Italy

Received 24 January 2014; Accepted 30 April 2014; Published 1 June 2014

Academic Editor: Danny N. Dhanasekaran

Copyright © 2014 Galyna Shuvayeva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Feun, M. You, C. J. Wu et al., “Arginine deprivation as a targeted therapy for cancer,” Current Pharmaceutical Design, vol. 14, no. 11, pp. 1049–1057, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. T. Kuo, N. Savaraj, and L. G. Feun, “Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes,” Oncotarget, vol. 1, no. 4, pp. 246–251, 2010. View at Google Scholar · View at Scopus
  3. B. Delage, D. A. Fennell, L. Nicholson et al., “Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer,” International Journal of Cancer, vol. 126, no. 12, pp. 2762–2772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Bertino, W. R. Waud, W. B. Parker, and M. Lubin, “Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: Current strategies,” Cancer Biology and Therapy, vol. 11, no. 7, pp. 627–632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Covini, S. Tardito, O. Bussolati et al., “Expanding targets for a metabolic therapy of cancer: L-Asparaginase,” Recent Patents on Anti-Cancer Drug Discovery, vol. 7, no. 1, pp. 4–13, 2012. View at Google Scholar · View at Scopus
  6. L. G. Feun, A. Marini, G. Walker et al., “Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase,” British Journal of Cancer, vol. 106, no. 9, pp. 1481–1485, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T.-S. Yang, S.-N. Lu, Y. Chao et al., “A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients,” British Journal of Cancer, vol. 103, no. 7, pp. 954–960, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. A. Ott, R. D. Carvajal, N. Pandit-Taskar et al., “Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma,” Investigational New Drugs, vol. 31, no. 2, pp. 425–434, 2013. View at Publisher · View at Google Scholar
  9. T. Yau, P. N. Cheng, P. Chan et al., “A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma,” Investigational New Drugs, vol. 31, no. 1, pp. 99–107, 2013. View at Publisher · View at Google Scholar
  10. T. L. Bowles, R. Kim, J. Galante et al., “Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase,” International Journal of Cancer, vol. 123, no. 8, pp. 1950–1955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. H. Kim, J. M. Coates, T. L. Bowles et al., “Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis,” Cancer Research, vol. 69, no. 2, pp. 700–708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-Y. Yoon, Y.-J. Shim, E.-H. Kim et al., “Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase,” International Journal of Cancer, vol. 120, no. 4, pp. 897–905, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. W. Szlosarek, A. Klabatsa, A. Pallaska et al., “In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion,” Clinical Cancer Research, vol. 12, no. 23, pp. 7126–7131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. L. J. Nicholson, P. R. Smith, L. Hiller et al., “Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer,” International Journal of Cancer, vol. 125, no. 6, pp. 1454–1463, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Vynnytska-Myronovska, Y. Bobak, Y. Garbe, C. Dittfeld, O. Stasyk, and L. A. Kunz-Schughart, “Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation,” International Journal of Cancer, vol. 130, no. 9, pp. 2164–2175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Vynnytska-Myronovska, Y. Kurlishchuk, Y. Bobak, C. Dittfeld, L. A. Kunz-Schughart, and O. Stasyk, “Three-dimensional environment renders cancer cells profoundly less susceptible to a single amino acid starvation,” Amino Acids, vol. 45, no. 5, pp. 1221–1230, 2013. View at Google Scholar
  17. S. M. Morris Jr., “Arginine: beyond protein,” American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 508S–512S, 2006. View at Google Scholar · View at Scopus
  18. Y. P. Bobak, B. O. Vynnytska, Y. V. Kurlishchuk, A. A. Sibirny, and O. V. Stasyk, “Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes,” Cell Biology International, vol. 34, no. 11, pp. 1085–1089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Kroemer, G. Mariño, and B. Levine, “Autophagy and the Integrated Stress Response,” Molecular Cell, vol. 40, no. 2, pp. 280–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Chomczynski and N. Sacchi, “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,” Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987. View at Google Scholar · View at Scopus
  21. D. J. Klionsky, F. C. Abdalla, H. Abeliovich et al., “Guidelines for the use and interpretation of assays for monitoring autophagy,” Autophagy, vol. 8, no. 4, pp. 445–544, 2012. View at Publisher · View at Google Scholar
  22. R. Castino, N. Bellio, C. Follo, D. Murphy, and C. Isidoro, “Inhibition of Pi3k class III-dependent autophagy prevents apoptosis and necrosis by oxidative stress in dopaminergic neuroblastoma cells,” Toxicological Sciences, vol. 117, no. 1, pp. 152–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. G. L. Peterson, “A simplification of the protein assay method of Lowry et al. Which is more generally applicable,” Analytical Biochemistry, vol. 83, no. 2, pp. 346–356, 1977. View at Google Scholar · View at Scopus
  24. N. F. Trincheri, C. Follo, G. Nicotra, C. Peracchio, R. Castino, and C. Isidoro, “Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes,” Carcinogenesis, vol. 29, no. 2, pp. 381–389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Savaraj, M. You, C. Wu, M. Wangpaichitr, M. T. Kuo, and L. G. Feun, “Arginine deprivation, autophagy, apoptosis (aaa) for the treatment of melanoma,” Current Molecular Medicine, vol. 10, no. 4, pp. 405–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Reyjal, K. Cormier, and S. Turcotte, “Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies,” Advances in Experimental Medicine and Biology, vol. 772, pp. 167–188, 2014. View at Publisher · View at Google Scholar
  27. Y.-Y. Chang, G. Juhász, P. Goraksha-Hicks et al., “Nutrient-dependent regulation of autophagy through the target of rapamycin pathway,” Biochemical Society Transactions, vol. 37, no. 1, pp. 232–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Yan and R. F. Lamb, “Amino acid sensing and regulation of mTORC1,” Seminars in Cell and Developmental Biology, vol. 23, no. 6, pp. 621–625, 2012. View at Publisher · View at Google Scholar
  29. K. Hara, K. Yonezawa, Q.-P. Weng, M. T. Kozlowski, C. Belham, and J. Avruch, “Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism,” The Journal of Biological Chemistry, vol. 273, no. 23, pp. 14484–14494, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. M. H. Stipanuk, “Macroautophagy and its role in nutrient homeostasis,” Nutrition Reviews, vol. 67, no. 12, pp. 677–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Morani, R. Titone, L. Pagano et al., “Autophagy and thyroid carcinogenesis: genetic and epigenetic links,” Endocrine Related Cancer, vol. 21, no. 1, pp. R13–R29, 2013. View at Publisher · View at Google Scholar
  32. S. Lorin, A. Hamaï, M. Mehrpour, and P. Codogno, “Autophagy regulation and its role in cancer,” Seminars in Cancer Biology, vol. 23, no. 5, pp. 361–379, 2013. View at Publisher · View at Google Scholar
  33. C. Peracchio, O. Alabiso, G. Valente, and C. Isidoro, “Involvement of autophagy in ovarian cancer: a working hypothesis,” Journal of Ovarian Research, vol. 5, no. 1, p. 22, 2012. View at Google Scholar
  34. J.-H. Sheen, R. Zoncu, D. Kim, and D. M. Sabatini, “Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo,” Cancer Cell, vol. 19, no. 5, pp. 613–628, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Shvets, E. Fass, and Z. Elazar, “Utilizing flow cytometry to monitor autophagy in living mammalian cells,” Autophagy, vol. 4, no. 5, pp. 621–628, 2008. View at Google Scholar · View at Scopus
  36. Z. Feng, H. Zhang, A. J. Levine, and S. Jin, “The coordinate regulation of the p53 and mTOR pathways in cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 23, pp. 8204–8209, 2005. View at Publisher · View at Google Scholar · View at Scopus